These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 8922787)

  • 1. Management of invasive candidal infections: results of a prospective, randomized, multicenter study of fluconazole versus amphotericin B and review of the literature.
    Anaissie EJ; Darouiche RO; Abi-Said D; Uzun O; Mera J; Gentry LO; Williams T; Kontoyiannis DP; Karl CL; Bodey GP
    Clin Infect Dis; 1996 Nov; 23(5):964-72. PubMed ID: 8922787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial.
    Kullberg BJ; Sobel JD; Ruhnke M; Pappas PG; Viscoli C; Rex JH; Cleary JD; Rubinstein E; Church LW; Brown JM; Schlamm HT; Oborska IT; Hilton F; Hodges MR
    Lancet; 2005 Oct 22-28; 366(9495):1435-42. PubMed ID: 16243088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluconazole versus amphotericin B in the treatment of hematogenous candidiasis: a matched cohort study.
    Anaissie EJ; Vartivarian SE; Abi-Said D; Uzun O; Pinczowski H; Kontoyiannis DP; Khoury P; Papadakis K; Gardner A; Raad II; Gilbreath J; Bodey GP
    Am J Med; 1996 Aug; 101(2):170-6. PubMed ID: 8757357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicenter randomized trial of fluconazole versus amphotericin B for treatment of candidemia in non-neutropenic patients. Canadian Candidemia Study Group.
    Phillips P; Shafran S; Garber G; Rotstein C; Smaill F; Fong I; Salit I; Miller M; Williams K; Conly JM; Singer J; Ioannou S
    Eur J Clin Microbiol Infect Dis; 1997 May; 16(5):337-45. PubMed ID: 9228472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized study comparing fluconazole with amphotericin B/5-flucytosine for the treatment of systemic Candida infections in intensive care patients.
    Abele-Horn M; Kopp A; Sternberg U; Ohly A; Dauber A; Russwurm W; Büchinger W; Nagengast O; Emmerling P
    Infection; 1996; 24(6):426-32. PubMed ID: 9007589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter, randomized trial of fluconazole versus amphotericin B for empiric antifungal therapy of febrile neutropenic patients with cancer.
    Winston DJ; Hathorn JW; Schuster MG; Schiller GJ; Territo MC
    Am J Med; 2000 Mar; 108(4):282-9. PubMed ID: 11014720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current treatment of candidemia in non-neutropenic patients. Amphotericin B or fluconazole? A retrospective study of 62 consecutive patients].
    Cobo Reinoso P; Aguado García JM; Lumbreras Bermejo C; Pérez Vela JL; Caballero Cubedo R; Sanz Sanz F; Noriega Rodríguez AR
    Rev Clin Esp; 1997 Dec; 197(12):799-803. PubMed ID: 9477669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized comparison of fluconazole with amphotericin B as empiric anti-fungal agents in cancer patients with prolonged fever and neutropenia.
    Malik IA; Moid I; Aziz Z; Khan S; Suleman M
    Am J Med; 1998 Dec; 105(6):478-83. PubMed ID: 9870832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventing fungal infection in neutropenic patients with acute leukemia: fluconazole compared with oral amphotericin B.
    Menichetti F; Del Favero A; Martino P; Bucaneve G; Micozzi A; D'Antonio D; Ricci P; Carotenuto M; Liso V; Nosari AM; Barbui T; Fasola G; Mandelli F;
    Ann Intern Med; 1994 Jun; 120(11):913-8. PubMed ID: 8172437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute.
    Rex JH; Bennett JE; Sugar AM; Pappas PG; van der Horst CM; Edwards JE; Washburn RG; Scheld WM; Karchmer AW; Dine AP
    N Engl J Med; 1994 Nov; 331(20):1325-30. PubMed ID: 7935701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of fluconazole in the treatment of candidal endophthalmitis.
    Akler ME; Vellend H; McNeely DM; Walmsley SL; Gold WL
    Clin Infect Dis; 1995 Mar; 20(3):657-64. PubMed ID: 7756492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of invasive candidal infections: systematic review and meta-analysis.
    Gafter-Gvili A; Vidal L; Goldberg E; Leibovici L; Paul M
    Mayo Clin Proc; 2008 Sep; 83(9):1011-21. PubMed ID: 18775201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluconazole versus amphotericin B in the treatment of esophageal candidiasis in cancer patients.
    Lake DE; Kunzweiler J; Beer M; Buell DN; Islam MZ
    Chemotherapy; 1996; 42(4):308-14. PubMed ID: 8804799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of fluconazole oral suspension and amphotericin B oral suspension in older patients with oropharyngeal candidosis. Multicentre Study Group.
    Taillandier J; Esnault Y; Alemanni M
    Age Ageing; 2000 Mar; 29(2):117-23. PubMed ID: 10791445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifungal treatment for invasive Candida infections: a mixed treatment comparison meta-analysis.
    Mills EJ; Perri D; Cooper C; Nachega JB; Wu P; Tleyjeh I; Phillips P
    Ann Clin Microbiol Antimicrob; 2009 Jun; 8():23. PubMed ID: 19558681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The fluconazole era: management of hematogenously disseminated candidiasis in the nonneutropenic patient.
    Kramer KM; Skaar DJ; Ackerman BH
    Pharmacotherapy; 1997; 17(3):538-48. PubMed ID: 9165556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The comparative efficacy of cilofungin, fluconazole and amphotericin B in disseminated Candida tropicalis infection in neutropenic mice.
    Fong IW; Bannatyne RM; Cheng PC
    Clin Invest Med; 1992 Oct; 15(5):434-9. PubMed ID: 1458716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects.
    Rex JH; Pappas PG; Karchmer AW; Sobel J; Edwards JE; Hadley S; Brass C; Vazquez JA; Chapman SW; Horowitz HW; Zervos M; McKinsey D; Lee J; Babinchak T; Bradsher RW; Cleary JD; Cohen DM; Danziger L; Goldman M; Goodman J; Hilton E; Hyslop NE; Kett DH; Lutz J; Rubin RH; Scheld WM; Schuster M; Simmons B; Stein DK; Washburn RG; Mautner L; Chu TC; Panzer H; Rosenstein RB; Booth J;
    Clin Infect Dis; 2003 May; 36(10):1221-8. PubMed ID: 12746765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic amphotericin B versus fluconazole in the management of antibiotic resistant neutropenic fever--preliminary observations from a pilot, exploratory study.
    Ellis ME; Halim MA; Spence D; Ernst P; Clink H; Kalin M; Baillie F; Greer W
    J Infect; 1995 Mar; 30(2):141-6. PubMed ID: 7636280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral fluconazole versus amphotericin B bladder irrigation for treatment of candidal funguria.
    Fan-Havard P; O'Donovan C; Smith SM; Oh J; Bamberger M; Eng RH
    Clin Infect Dis; 1995 Oct; 21(4):960-5. PubMed ID: 8645847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.